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Genome research using appropriately collected pathological
tissue samples is expected to yield breakthroughs in the
development of biomarkers and identiﬁcation of therapeutic
targets for diseases such as cancers. In this connection, the
Japanese Society of Pathology (JSP) has developed “The
JSP Guidelines on the Handling of Pathological Tissue
Samples for Genomic Research” based on an abundance of
data from empirical analyses of tissue samples collected and
stored under various conditions. Tissue samples should be
collected from appropriate sites within surgically resected
specimens, without disturbing the features on which patho-
logical diagnosis is based, while avoiding bleeding or
necrotic foci. They should be collected as soon as possible
after resection: at the latest within about 3h of storage at
4°C. Preferably, snap-frozen samples should be stored in
liquid nitrogen (about 180°C) until use. When intending to
use genomic DNA extracted from formalin-ﬁxed parafﬁn-
embedded tissue, 10% neutral buffered formalin should be
used. Insufﬁcient ﬁxation and overﬁxation must both be
avoided. We hope that pathologists, clinicians, clinical labo-
ratory technicians and biobank operators will come to master
the handling of pathological tissue samples based on the
standard operating procedures in these Guidelines to yield
results that will assist in the realization of genomic medicine.
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The original version of “The Japanese Society of Pathology (JSP)
Guidelines on the Handling of Pathological Tissue Samples for
Genomic Research” appeared in Japanese as Genome Kenkyu-
yo Byori Soshiki Kentai Toriatsukai Kitei from the JSP, Tokyo, in
2016 (http://pathology.or.jp/genome/). In addition to two parts that
appeared in this special article, the Japanese version of “The JSP
Guidelines on the Handling of Pathological Tissue Samples for
Genomic Research” includes a part pertaining to “Appropriate
Sites for Sample Collection in Surgically Resected Materials”. Two
parts of the Guidelines based on our empirical analyses, i.e., “Part
1: Appropriate methods for collection, storage, and transport of
frozen tissue samples” and “Part 2: Appropriate methods for
preparation and storage of formalin-fixed paraffin-embedded
(FFPE) specimens”, are here incorporated into this English-
language article.
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At the present time, which has seen rapid strides in the
development of omics analysis technologies, such as
genome analysis,1,2 it is expected that data-driven studies
based on analysis of clinical samples will help clarify the
molecular mechanisms responsible for the occurrence,
progression and treatment responsiveness of diseases,
thereby leading to the development of new biomarkers for
diagnosis and identiﬁcation of drug discovery targets.3 In
particular, analysis of pathological tissue samples collected
from the exact site of a disease, such as cancer, will be
indispensable for the realization of genomic medicine.4–12
Besides detailed and accurate clinicopathological informa-
tion about pathological tissue samples, the quality of the
tissue samples itself holds the key to the success of such
data-driven studies.13,14 Appropriate collection and storage of
pathological tissue samples enables reliable and high-quality
analyses that can contribute to prevention and treatment of
diseases.15 To make appropriate pathological tissue samples
available to a wide range of medical researchers, there have
been active movements toward the development and man-
agement of biobanks at various institutions.16 On the other
hand, not uncommonly, researchers may be confounded by
uninterpretable artifacts that are encountered during analysis
of samples of varying quality because of inappropriate
collection and storage methods,17 and biobank operators do
not have access to proper means of maintaining sample
quality, despite a high level of motivation. In this connection,
the Japanese Society of Pathology (JSP) has developed “The
JSP Guidelines on the Handling of Pathological Tissue
Samples for Genomic Research” (referred to hereafter as
“the Guidelines”) to facilitate the collection of adequate
amounts of high-quality pathological tissue samples suitable
for omics studies, including genome research.18
This paper includes two parts of the Guidelines, “Part 1:
Appropriate methods for collection, storage, and transport
of frozen tissue samples” and “Part 2: Appropriate methods
for preparation and storage of formalin-ﬁxed parafﬁn-
embedded (FFPE) specimens”, which have been compiled
on the basis of abundant data obtained from empirical
analyses of tissue samples actually collected and stored
under various conditions. The authors, who belong to the
“Editorial Committee on The Guidelines for Handling of
Pathological Tissue Samples for Genomic Research” (Chair:
Yae Kanai) of the JSP, and who are engaged in the
development and management of biobanks at their own
institutions, have performed empirical analyses in order to
develop the two parts of the Guideline. Such analyses were
approved by the Ethics Committees of the National Cancer
Center, Tokyo, Keio University School of Medicine, Hokkaido
University Graduate School of Medicine, Kanagawa Cancer
Center Research Institute, Kyoto University Graduate School
of Medicine, and Tokyo Medical and Dental University, and
were performed in accordance with the Declaration of
Helsinki. All of the patients concerned provided written
informed consent prior to inclusion in the study.
In order to make the Guidelines widely applicable to
genomic studies, they were reviewed and approved by the
“Advisory Council for Developing the Guidelines on the
Handling of Pathological Tissue Samples for Genomic
Research” (Chair: Hitoshi Nakagama), consisting of repre-
sentatives from BioBank Japan (BBJ),19 the National Center
Biobank Network (NCBN),20 the National Hospital Organiza-
tion (NHO), the Japan Clinical Oncology Group (JCOG),21
the Japan Children's Cancer Group (JCCG), and the
Japanese Cancer Association (JCA).22
The Guidelines provide practical descriptions of optimized
procedures for the collection and storage of pathological
tissue samples. We believe that, by reference to these
empirical analysis data, readers will be able to choose the
methods most suited to the actual situations at their
respective institutions. We hope that pathologists, clinicians,
clinical laboratory technicians and biobank operators will
come to master the handling of pathological tissue samples.
We also expect that researchers will come to understand
the labor that goes into the collection of reliable pathological
tissue samples and acquire good knowledge of the charac-
teristic features of each sample before starting their analy-
sis. It is our desire that the Guidelines are taken fully into
account when conducting data-driven studies, in order to
contribute to the realization of genomic medicine.
PART 1: APPROPRIATE METHODS FOR COLLECTION,
STORAGE, AND TRANSPORT OF FROZEN TISSUE
SAMPLES
The information in this section is intended to minimize the
degeneration of DNA, RNA and proteins in frozen samples,
to enable long-term storage and maintenance of tissue
samples of high quality, and to maximize the versatility of
such samples to allow their use in various analyses in the
future. Explanatory notes are as follows:
 (E) means “issues that cannot be deemed essential
because of excessive workload, although high quality
better than (A) could be expected”;
 (A) means “recommended issues”;
 (B) means “recommended issues when (A) issues are
not feasible”; and
 (N) “issues that should be avoided”.
Collection of pathological tissue samples
1.1. Tissue samples to be used for genomic studies should be
collected from appropriate sites within the surgical specimens,
without disturbing the features on which pathological diagnosis
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is based (without posing any disadvantage to the patient),
while avoiding bleeding or necrotic foci where degeneration of
nucleic acids and proteins can be expected (A).
Note: In cases of broad/comprehensive consent, it seems
common policy for biopsy specimens not to be stored for
biobanking after diagnosis and treatment. Therefore, the
handling process for tissue samples collected from surgical
specimens for genomic studies are ﬁrst described in this
section.
Note: In cases of individual consent, the use of biopsy
specimens for genomic studies should conform to the rules
in and after item 16 in Part 1, “Snap freezing”.
1.2. From patients with cancer, both cancerous and non-
cancerous tissue (appropriate control tissue) should be
collected (A).
Note: In general, cancerous tissue is heterogeneous in
nature. Particularly, if macroscopic heterogeneity is evident,
it is desirable to collect tissue specimens from multiple sites
within the cancerous lesion (E).
1.3. A description of the site of collection, e.g., lesser
curvature of the gastric body or segment X of the liver,
should be given (A).
Note: It is also desirable to facilitate conveyance of
information about the site of collection to the researchers by
some means, including an indication of the approximate site
of collection in a photo or schema, and recording of the
block number prepared from an adjacent part for routine
pathological diagnosis (E).
Note: When tissue is collected from multiple sites within a
lesion, it is also desirable to describe the noteworthy
macroscopic features in writing (E).
Person in charge of sample collection
1.4. In the case of surgical specimens, it is preferable for a
board-certiﬁed pathologist to determine the propriety of
tissue sample collection, the appropriate site of collection,
and the appropriate amount of tissue to be collected (E).
Alternatively, clinicians with relevant expertise who are
familiar with the pathological diagnosis and possesses
adequate ability for macroscopic pathological diagnosis
may also make the judgment (A).
Note: About 2400 board-certiﬁed pathologists, who have
passed qualiﬁcation examinations consisting of a written
examination, practical examination and an interview, were
registered in JSP as of October, 2017. Before taking the
qualiﬁcation examination, each applicant has to obtain a
Japanese doctor's license and complete two years of clinical
training as well as three years of pathological training
(histopathological diagnosis of more than 5000 cases, more
than 30 autopsies, attendance at assigned seminars, and
publication of papers focusing on human pathology).
1.5. Any pathology residents, clinical training physicians,
clinical laboratory technicians or other biobank operators
who are assigned responsibility for tissue collection should
have appropriate training about suitable collection sites, as
described in item 1.1 above, and should always collect
samples under the supervision of a board-certiﬁed patholo-
gist or clinician in the relevant specialty who is familiar with
pathological diagnosis (B).
Time of collection
1.6. Tissue samples for use in genomic research should be
collected from the surgical specimen as soon as possible
after resection (A) (Figs. 1, 2 and Tables 1, 2).
Note: Keeping surgical specimens at room temperature
for prolonged periods (more than 30min) should be avoided
(N) (Figs. 1, 2 and Tables 1, 2).
1.7. If the samples cannot be collected quickly, the
surgical specimen should be kept at 4°C in a refrigerator.
Tissue samples should be collected within about 3 h of
storage at 4°C (B) (Figs. 1, 2 and Tables 1, 2).
Note: The quality of nucleic acids may depend on the
techniques used by the researcher receiving the samples
from the biobank rather than on the conditions of collection
and storage at the biobank (Fig. 3).
1.8. When samples are provided from biobanks to
researchers, the standard operating procedure (SOP),
including the time and temperature at the institutions,
should be disclosed (A). If there is deviation from the SOP
at any institution, records of deviations in time, temperature
and/or other items should be included in the sample-
associated information (A).
Note: It is desirable to accurately record the time of
sample collection or the time required for sampling after
resection and the temperature of the specimen until sam-
pling (E). However, as long as samples are collected
according to the institutional SOP, the quality of the sample
is predictable.
Note: The workload for recording the duration of intra-
operative ischemia by reviewing the patient's medical
records (E) is excessive, considering its relevance. How-
ever, it is desirable that a system for disclosing the duration
of intraoperative ischemia be available upon request from
researchers conducting studies whose results are inﬂu-
enced by the ischemia time (A).
Sample collection quantity
1.9. The quantity of the samples to be collected should be
judged by a board-certiﬁed pathologist or clinician in the
relevant specialty who is familiar with pathological diagno-
sis, in order to avoid any pitfalls in such diagnosis, as
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Figure 1 Effects of time until snap freezing and storage temperature on the quality of genomic DNA. Using tissue pieces of almost the same
size (2 to 3mm3) collected from the same site (non-cancerous and cancerous parts) of a surgical specimen from the same patient, with
varying times until snap freezing and storage temperatures, genomic DNA was extracted by the phenol-chloroform method to compare the
quality of the genomic DNA. The processing procedures for comparison were as follows: #1, Snap freezing in liquid nitrogen immediately after
surgical resection; #2, Snap freezing in liquid nitrogen after 3 h of storage at 4°C; #3, Snap freezing in liquid nitrogen after 6 h of storage at
4°C; #4, Snap freezing in liquid nitrogen after 24h of storage at 4°C; #5, Snap freezing in liquid nitrogen after 3 h of storage at room
temperature; #6, Snap freezing in liquid nitrogen after 6 h of storage at room temperature; #7, Snap freezing in liquid nitrogen after 24h of
storage at room temperature. TSP, tissue sample for the Japanese Society of Pathology. The quality of the DNA was assessed by agarose gel
electrophoresis, in terms of the DNA integrity number (DIN) measured in a 2200 TapeStation system (Agilent, Santa Clara, CA, USA), and by
genomic PCR with ampliﬁcation lengths of 1241bp and 2823bp. With any processing procedure, PCR ampliﬁcation was possible for DNA
fragments of 2823 bp, but degradation of genomic DNA was evident on agarose gel in cases of liver TSP-1 stored for many hours at 4°C or
stored at room temperature (red arrows). There was a marked decrease in the DIN value in liver cases TSP-1 and TSP-12 with prolonged time
until snap freezing and increased storage temperature. The effects of prolonged storage at 4°C and storage at room temperature on the quality
of the DNA were generally milder in samples obtained from the gastrointestinal tract than in those from the liver. However, analysis of all the
samples examined also showed a signiﬁcant decrease in the DIN value following storage for 24h at 4°C and storage at room temperature
(Table 1). The specimens should be submitted for snap freezing as quickly as possible after surgical resection, and even if the specimen
cannot be processed immediately, it is desirable that snap freezing be performed after storage for the shortest period of time at 4°C. The data
in this ﬁgure suggest that storage for 6 h at 4°C is permissible. However, it is concluded that snap freezing should be conducted within about
3 h of storage at 4°C, because the quality of the RNA from some organs deteriorates after storage for 6 h at 4°C, as shown in Fig. 2.
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Figure 2 Effects of time until snap freezing and storage temperature on RNA quality. Using tissue pieces of almost the same size (2 to
3mm3) collected from the same site (non-cancerous and cancerous parts) of a surgical specimen from the same patient, with varying times
until snap freezing and storage temperatures, total RNA was extracted using TRIzol (Thermo Fisher, Waltham, MA) to compare the quality
of the RNA. The processing procedures for comparison were as follows: #1, Snap freezing in liquid nitrogen immediately after surgical
resection; #2, Snap freezing in liquid nitrogen after 3 h of storage at 4°C; #3, Snap freezing in liquid nitrogen after 6 h of storage at 4°C; #4,
Snap freezing in liquid nitrogen after 24 h of storage at 4°C; #5, Snap freezing in liquid nitrogen after 3 h of storage at room temperature; #6,
Snap freezing in liquid nitrogen after 6 h of storage at room temperature; #7, Snap freezing in liquid nitrogen after 24 h of storage at room
temperature. RNA quality was assessed in terms of the RNA integrity number (RIN) measured in a 2100 Bioanalyzer system (Agilent), and
reverse transcription (RT)-PCR with an ampliﬁcation length of 994 bp. It was shown that there were variations in the effects of time until
freezing and storage temperature on the quality of RNA among samples obtained from different organs. According to our analysis, the
effects of prolonged storage at 4°C and storage at room temperature on RNA quality were generally milder in samples obtained from the
gastrointestinal tract, particularly gastric mucosa, than in those obtained from the liver. Therefore, when all the samples examined were
analyzed, the decrease in the RIN value was not statistically signiﬁcant, unless the samples had been stored for many hours at room
temperature (Table 2). However, for liver cases TSP-1 and TSP-12, there was a marked decrease in the RIN value with prolonged time until
snap freezing and increased storage temperature. In the cases liver TSP-12 and colon TSP-9, etc., the RIN value began to decrease after
6 h of storage at 4°C. It is concluded that the processing should be conducted as quickly as possible, and even if the specimen cannot be
processed immediately, snap freezing should be conducted within 3 h of storage at 4°C.
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speciﬁed in item 1.4. However, if there is no particular
difﬁculty with pathological diagnosis, and an appropriate site
of collection is available, it is appropriate to collect tissue
samples about half the size of a little ﬁngertip (about
1 0.5 0.3 cm, 50–100mg) (A).
Note: Even very small tissue samples may allow useful
analysis. Therefore, there is no need to hesitate about
collecting a sample simply because the amount of tissue
involved is smaller than half a little ﬁngertip in size (B).
Note: The weighing procedure has a disadvantage in that
it prolongs the time until snap freezing. Weighing the whole
collected tissue may not necessarily be useful for research-
ers, because cut tissue fragments are given to researchers,
and weighing each of these would further prolong the time
until snap freezing. If analysis that requires normalization by
the wet weight of a tissue sample or other processing
procedures that employ wet weight is highly likely, it is
desirable to measure the wet weight of the tissue sample
using an accurate measuring instrument (E).
Tissue processing
1.10. The tissue collected should be cut into pieces 2–3mm
square (A).
Note: It is indispensable to cut the tissue into pieces
before snap freezing in order to prevent repeated freezing
and thawing of any tissue other than that to be used, and to
Table 1 Effects of time until snap freezing and storage temperature on the quality of genomic DNA
DNA integrity number
Procedure
Number of analyzed
tissue specimens†
Yielded genomic
DNA (mg) A260/A280 MeanSD
P-value against #1
(Welch-t test)
#1 Snap freezing in liquid nitrogen immediately
after surgical resection
12 190.0104.0 1.870.03 9.50.5 –
#2 Snap freezing in liquid nitrogen after 3 h of
storage at 4°C
12 206.5173.2 1.880.04 9.20.7 3.50101
#3 Snap freezing in liquid nitrogen after 6 h of
storage at 4°C
11 196.090.3 1.870.03 9.40.3 7.49101
#4 Snap freezing in liquid nitrogen after 24 h of
storage at 4°C
12 197.1117.5 1.870.03 8.80.7 1.62102
#5 Snap freezing in liquid nitrogen after 3 h of
storage at room temperature
12 195.2106.0 1.890.02 8.50.8 1.65103
#6 Snap freezing in liquid nitrogen after 6 h of
storage at room temperature
11 164.8174.2 1.880.05 7.81.6 2.77103
#7 Snap freezing in liquid nitrogen after 24 h of
storage at room temperature
12 192.8105.6 1.880.03 6.61.3 6.00107
Cases with P< 0.05 are underlined. Also see Fig. 1.
†Detailed description of analyzed tissue specimens is shown in the legend for Fig. 1.
Table 2 Effects of time until snap freezing and storage temperature on the quality of RNA
RNA integrity number
Procedure
Number of analyzed
tissue specimens†
Yielded total
RNA (mg) A260/A280 MeanSD
P-value against #1
(Welch-t test)
#1 Snap freezing in liquid nitrogen immediately
after surgical resection
12 118.353.0 2.100.07 6.70.5 –
#2 Snap freezing in liquid nitrogen after 3 h of
storage at 4°C
12 98.449.0 2.130.14 6.70.5 7.59101
#3 Snap freezing in liquid nitrogen after 6 h of
storage at 4°C
11 91.536.7 2.120.06 6.50.6 4.45101
#4 Snap freezing in liquid nitrogen after 24 h of
storage at 4°C
12 101.141.0 2.100.07 6.40.8 3.59101
#5 Snap freezing in liquid nitrogen after 3 h of
storage at room temperature
12 102.647.8 2.110.06 6.21.0 1.29101
#6 Snap freezing in liquid nitrogen after 6 h of
storage at room temperature
11 85.345.1 2.120.14 6.41.0 3.53101
#7 Snap freezing in liquid nitrogen after 24 h of
storage at room temperature
12 81.142.7 2.110.08 5.11.5 3.12103
Cases with P< 0.05 are underlined. Also see Fig. 2.
†Detailed description of analyzed tissue specimens is shown in the legend for Fig. 2.
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rapidly conduct high-quality analysis while preventing acti-
vation of nucleases. (A).
1.11. Preferably, one cubical 2–3mm tissue sample
should be contained in one tube (E). When there is a
limitation on the availability of storage containers, more than
one tissue piece may be accommodated in one tube, while
ensuring that the pieces are adherent to the inner wall of
the tube and separate from one another (A).
Note: If the tissue pieces adhere to the inner wall of the
tube separately from one another, the necessary number of
individual pieces can be removed quickly with forceps,
before the temperature of the tube containing the remaining
tissue pieces increases.
Note: If there is more than one tissue piece per tube, it
may be easier to use 1.5mL to 2mL volume tubes (A), but
this is not the case when each tube contains only one piece
of tissue.
1.12. Ultralow-temperature-resistant tubes should be
used (A). Also, when writing or labeling the anonymized
number or other marks on the tube, an ultralow-tempera-
ture-resistant marker or label should be used (A).
Note: It is desirable for tubes, markers and labels
to be actually tested in advance for their ultralow
temperature resistance at the storage facility in each
institution (E).
Note: Depending on the management system at each
institution, the use of tubes on which bar codes or other
codes of anonymized numbers are printed is also recom-
mended (E).
1.13. In order to prepare for unexpected temperature
alterations (to prevent accidents due to expansion of liquid
nitrogen), tubes with screw caps should be used (A).
1.14. Several tubes of samples described in item 1.11
should be prepared for each tissue collection site (for
example cancerous and non-cancerous parts) (A).
Note: Even when more than one piece of tissue is
contained in one tube, several tubes of samples should
always be prepared, considering the convenience of storage
at several places or provision to several researchers (A).
Note: If consensus is obtained from each institution, or
particularly when storage of high-quality samples in a liquid
nitrogen container is feasible, it is desirable to store some
of the multiple sample tubes for a long period (e.g., more
than 10 years) for future use in research using advanced
analytical techniques (E).
1.15. A number of nucleic acid stabilization/preservation
agents are commercially available, and tissue pieces are
frequently immersed in a nucleic acid stabilization/preserva-
tion agent in tubes and frozen. However, at institutions where
collection and snap freezing of tissue samples can be
conducted as quickly as possible, it is also recommended
not to use nucleic acid stabilization/preservation agents to
ensure that the quality of the nucleic acids is maintained and
the general versatility of the sample maximized.
Note: If tissue samples frozen in a nucleic acid stabiliza-
tion/preservation agent are used for nucleic acid extraction,
the quality of the DNA will generally not be affected (Fig. 4
and Table 3).
Figure 3 Effects of the extraction technique used on RNA quality. Using 7 groups of tissue specimens of almost the same size (2 to
3mm3) collected from the same site (non-cancerous part) of surgical specimens (various organs) from the same patient, RNA was extracted
using different methods after storage under the same conditions (–80°C) to compare the quality of the RNA. The quality of RNA was
assessed by RNA integrity number (RIN) measurement in a 2200 TapeStation system. Even for the same samples stored under the same
conditions, the results varied greatly according to the method of extraction. Crushing of the sample in liquid nitrogen without thawing yielded
higher-quality RNA, even in samples L1, L2, L4 and L6, in which low-quality RNA was provided by an automatic extraction apparatus using
beads. The relevance of the quality of the RNA ﬁnally obtained may depend on the procedure that has been employed by the researcher,
rather than the conditions of sample collection or storage at the biobank. If necessary, biobank operators should promote awareness about
the proper choice of the procedure by the user. Biobanks that extract RNA by themselves for provision to researchers must also choose the
most appropriate procedures.
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Figure 4 Effects of nucleic acid stabilization/preservation agents from various manufacturers on the quality of genomic DNA. Using tissue pieces
of almost the same size (2 to 3mm3 cubes) collected from the same site (non-cancerous part) of a surgical specimen from the same patient,
genomic DNA was extracted by the phenol-chloroform method after immersion in various nucleic acid stabilization/preservation agents and
storage for a certain period of time in liquid nitrogen to compare the quality of the genomic DNA. The processing procedures for comparison were
as follows: #1, Snap freezing in liquid nitrogen without the use of any nucleic acid stabilization/preservation agent immediately after surgical
resection; #8, Snap freezing in liquid nitrogen after immersion in nucleic acid stabilization/preservation agent A immediately after surgical resection;
#9, Snap freezing in liquid nitrogen after immersion in nucleic acid stabilization/preservation agent L immediately after surgical resection; #10,
Snap freezing in liquid nitrogen after immersion in nucleic acid stabilization/preservation agent P immediately after surgical resection; #11, Snap
freezing in liquid nitrogen after immersion in nucleic acid stabilization/preservation agent S immediately after surgical resection. The quality of the
DNA was assessed by agarose gel electrophoresis, in terms of the DNA integrity number (DIN) measured in an 2200 TapeStation system (also
see Table 3), and by genomic PCR with ampliﬁcation lengths of 1241bp and 2823bp. When tissue samples frozen in nucleic acid stabilization/
preservation agents were subjected to nucleic acid extraction, there was generally no inﬂuence on the quality of the DNA.
Table 3 Effects of nucleic acid stabilization/preservation agents from various manufacturers on the quality of genomic DNA
DNA integrity number
Procedure
Number of
analyzed tissue
specimens†
Yielded genomic
DNA (mg) A260/A280 MeanSD
P-value against
#1 (Welch-t test)
#1 Snap freezing in liquid nitrogen without the use of any
nucleic acid stabilization/preservation agent
immediately after surgical resection
12 190.0 104.0 1.87 0.03 9.5 0.5 –
#8 Snap freezing in liquid nitrogen after immersion in
nucleic acid stabilization/preservation agent A
immediately after surgical resection
4 361.7 186.6 1.90 0.05 9.8 0.1 9.58 102
#9 Snap freezing in liquid nitrogen after immersion in
nucleic acid stabilization/preservation agent L
immediately after surgical resection
4 197.9 112.7 1.93 0.06 9.7 0.1 2.08 101
#10 Snap freezing in liquid nitrogen after immersion in
nucleic acid stabilization/preservation agent P
immediately after surgical resection
4 308.0 70.2 1.90 0.07 9.7 0.2 4.94 101
#11 Snap freezing in liquid nitrogen after immersion in
nucleic acid stabilization/preservation agent S
immediately after surgical resection
4 304.8 103.7 1.93 0.06 9.7 0.3 4.47 101
†Detailed description of analyzed tissue specimens is shown in the legend for Fig. 4. Also see Fig. 4.
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Note: On the other hand, the effects on RNA vary largely
according to the type of nucleic acid stabilization/preserva-
tion agent used. If a nucleic acid stabilization/preservation
agent is employed, the most appropriate one should be
chosen based on quality that has been veriﬁed by actual
extraction of nucleic acids at each institution (Fig. 5 and
Table 4).
Note: If tissue samples frozen in a nucleic acid stabilization/
preservation agent are used for nucleic acid extraction, the
quality of the RNA extracted may be poorer because, for
Figure 5 Effects of nucleic acid stabilization/preservation agents from various manufacturers on RNA quality. Using tissue pieces of almost
the same size (2 to 3mm3) collected from the same site (non-cancerous part) of a surgical specimen from the same patient, total RNA was
extracted using TRIzol after immersion in various nucleic acid stabilization/preservation agents and storage for a certain period of time in
liquid nitrogen to compare the quality of the RNA. The processing procedures for comparison were as follows: #1, Snap freezing in liquid
nitrogen without the use of any nucleic acid stabilization/preservation agent immediately after surgical resection; #8, Snap freezing in liquid
nitrogen after immersion in nucleic acid stabilization/preservation agent A immediately after surgical resection; #9, Snap freezing in liquid
nitrogen after immersion in nucleic acid stabilization/preservation agent L immediately after surgical resection; #10, Snap freezing in liquid
nitrogen after immersion in nucleic acid stabilization/preservation agent P immediately after surgical resection; #11, Snap freezing in liquid
nitrogen after immersion in nucleic acid stabilization/preservation agent S immediately after surgical resection. The quality of the RNA was
assessed in terms of the RNA integrity number (RIN) measured in a 2100 Bioanalyzer system (also see Table 4), and by reverse
transcription (RT)-PCR with an ampliﬁcation length of 994 bp. There were considerable variations in the effect on RNA quality depending on
the type of nucleic acid stabilization/preservation agent used. If tissue samples frozen in a nucleic acid stabilization/preservation agent are
subjected to nucleic acid extraction, the quality of the RNA extracted may be decreased, e.g., because additional time is needed for thawing
the nucleic acid stabilization/preservation agent, in comparison to extraction of nucleic acids from tissue samples frozen without the use of
nucleic acid stabilization/preservation agents.
Table 4 Effects of nucleic acid stabilization/preservation agents from various manufactures on the quality of RNA
RNA integrity number
Procedure
Number of
analyzed tissue
specimens†
Yielded total
RNA (mg) A260/A280 MeanSD
P-value
against #1
(Welch-t test)
#1 Snap freezing in liquid nitrogen without the use of any
nucleic acid stabilization/preservation agent
immediately after surgical resection
12 190.0104.0 1.870.03 9.50.5 –
#8 Snap freezing in liquid nitrogen after immersion in nucleic
acid stabilization/preservation agent A immediately
after surgical resection
4 96.044.0 2.080.05 4.61.2 4.09102
#9 Snap freezing in liquid nitrogen after immersion in nucleic
acid stabilization/preservation agent L immediately after
surgical resection
5 98.841.3 2.080.04 5.60.4 4.55104
#10 Snap freezing in liquid nitrogen after immersion in nucleic
acid stabilization/preservation agent P immediately
after surgical resection
5 69.345.6 2.080.03 2.50.3 8.521012
#11 Snap freezing in liquid nitrogen after immersion in nucleic
acid stabilization/preservation agent S immediately
after surgical resection
5 88.137.5 2.070.05 3.30.8 2.33104
Cases with P< 0.05 are underlined. Also see Fig. 5.
†Detailed description of analyzed tissue specimens is shown in the legend for Fig. 5.
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example, additional time may be needed for thawing of the
agent, as compared to that for extraction of nucleic acids from
tissue samples that have been simply frozen without the use
of nucleic acid stabilization/preservation agents (Fig. 5 and
Table 4).
Snap freezing
1.16. Multiple sample tubes prepared according to item 1.14
should be rapidly frozen in liquid nitrogen (A).
Note: Tubes should be rapidly frozen by immersing them
in corked Dewar bottles (double-wall insulated containers)
containing liquid nitrogen (A).
Note: At institutions where samples are collected fre-
quently (many each day), it is efﬁcient to keep relatively
small (about 30–50L) liquid nitrogen storage containers for
prompt snap freezing in surgical specimen processing rooms
or other appropriate locations where fresh unﬁxed surgical
specimens are handled, and to place the sample tubes
prepared according to item 1.14 into these liquid nitrogen
containers (E). This allows sufﬁciently frozen samples to be
delivered regularly in bulk to long-term storage facilities.
Note: At institutions where liquid nitrogen is not readily
available in surgical specimen processing rooms, the use of
dry ice-acetone or other techniques may be useful alter-
natives for freezing (B) (Figs. 6, 7 and Tables 5, 6).
Note: At institutions where liquid nitrogen is not readily
available in surgical specimen processing rooms, an ultra-
deep freezer (–80°C) can be kept in the room, making it
possible to promptly freeze any sample tubes (B) (Figs. 6, 7
and Tables 5, 6).
Long-term storage
1.17. It is preferable for snap-frozen sample tubes prepared
according to item 1.16 to be stored in liquid nitrogen
storage containers (about 180°C) until use for research
purposes (A).
Note: Here, “long-term storage” means storage until use
for research purposes. In general, equipment and standard
procedures should be selected with a view to storage for
5–10 years or longer.
Note: Normally, gas-phase liquid nitrogen storage con-
tainers are used (A). It is desirable to use an isothermal-
type liquid nitrogen storage container completely without
liquid nitrogen in its inner tank, in order to avoid contamina-
tion by pathogenic microorganisms (E). However, from
the viewpoint of cost-effectiveness, introduction of an
Figure 6 Effects of the freezing method on the quality of genomic DNA. Using tissue pieces of almost the same size (2 to 3mm3) collected
from the same site (non-cancerous and cancerous parts) of a surgical specimen from the same patient, genomic DNA was extracted by the
phenol-chloroform method after freezing by various methods and storage for a certain period of time, to compare the quality of the genomic
DNA. The processing procedures for comparison were as follows: #1, The tubes containing the tissue samples were rapidly frozen in liquid
nitrogen immediately after surgical resection; #12: The tubes containing the tissue samples were frozen in dry ice-acetone immediately after
surgical resection, #13: The tubes containing the tissue samples were frozen and stored in an ultra-deep freezer (–80°C) immediately after
surgical resection. The quality of the DNA was assessed by agarose gel electrophoresis, in terms of the DNA integrity number (DIN)
measured in a 2200 TapeStation system, and by genomic PCR with ampliﬁcation lengths of 1241bp and 2823 bp. Even when the samples
were frozen in dry ice-acetone or an ultra-deep freezer, instead of in liquid nitrogen, there was no marked inﬂuence on the quality of the
DNA, as long as the storage period until analysis was short (also see Table 5).
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isothermal-type container is left to the discretion of each
individual institution.
Note: Liquid nitrogen-containing corked Dewar bottles
(double-wall insulating containers) or other containers
that have low thermal conductivity and adequate heat
insulation capacity should be used for delivery to
long-term storage facilities, even those within the
institution.
Figure 7 Effects of the freezing method on the quality of RNA. Using tissue pieces of almost the same size (2 to 3mm3) collected from the
same site (non-cancerous and cancerous parts) of a surgical specimen from the same patient, total RNA was extracted using TRIzol after
freezing by various methods and storage for a certain period of time to compare the quality of the RNA. The processing procedures for
comparison were as follows: #1, The tubes containing the tissue samples were rapidly frozen in liquid nitrogen immediately after surgical
resection; #12, The tubes containing the tissue samples were frozen in dry ice-acetone immediately after surgical resection; #13, The tubes
containing the tissue samples were frozen and stored in an ultra-deep freezer (–80°C) immediately after surgical resection. The quality of the
RNA was assessed in terms of the RNA integrity number (RIN) measured in a 2100 Bioanalyzer system, and by reverse transcription (RT)-
PCR with an ampliﬁcation length of 994bp. Even when the samples were frozen in dry ice-acetone or an ultra-deep freezer, instead of in liquid
nitrogen, there was no marked inﬂuence on the quality of the RNA as long as the storage period until analysis was short (also see Table 6).
Table 5 Effects of the freezing method on the quality of genomic DNA
DNA integrity number
Procedure
Number of
analyzed tissue
specimens†
Yielded
genomic
DNA (mg) A260/A280 MeanSD
P-value
against #1
(Welch-t test)
#1 The tubes containing the tissue samples were rapidly
frozen in liquid nitrogen immediately after surgical
resection
12 190.0104.0 1.870.03 9.50.5 –
#12 The tubes containing the tissue samples were frozen in
dry ice-acetone immediately after surgical resection
11 162.379.3 1.870.03 9.20.8 3.70101
#13 The tubes containing the tissue samples were frozen in
ultra-deep freezer (–80°C) immediately after surgical
resection
11 158.165.8 1.890.04 9.40.6 8.66101
†Detailed description of analyzed tissue specimens is shown in the legend for Fig. 6. Also see Fig. 6.
Table 6 Effects of the method of freezing used on the quality of RNA
RNA integrity number
Procedure
Number of
analyzed tissue
specimens†
Yielded total
RNA (mg) A260/A280 MeanSD
P-value
against #1
(Welch-t test)
#1 The tubes containing the tissue samples were rapidly
frozen in liquid nitrogen immediately after surgical
resection
12 190.0104.0 1.870.03 9.50.5 –
#12 The tubes containing the tissue samples were frozen in
dry ice-acetone immediately after surgical resection
11 77.945.5 2.110.07 6.60.7 8.81101
#13 The tubes containing the tissue samples were frozen in
ultra-deep freezer (–80°C) immediately after surgical
resection
11 87.353.0 2.100.08 6.80.7 5.77101
†Detailed description of analyzed tissue specimens is shown in the legend for Fig. 7. Also see Fig. 7.
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Note: Operations such as placement of sample tubes into
a liquid nitrogen container for long-term storage are usually
conducted manually, but as quickly as possible, to minimize
any changes in sample temperature (A).
Note: From the viewpoint of quality preservation and
labor-saving, it is also desirable to have a system at liquid
nitrogen storage facilities to distinguish anonymized number
bar codes or other types of codes printed on sample tubes,
and a system for managing automatic robotic delivery in
and out of the storage facility. A large outdoor liquid
nitrogen storage tank and an automated system for supply-
ing liquid nitrogen from it to each indoor container are also
desirable (E). However, the long-term storage facility cho-
sen at each institution should take cost-effectiveness into
account.
1.18. When the sample tubes are placed in liquid nitrogen
storage containers for long-term storage, sample-associated
information including the place of storage of the sample
should be registered in the appropriate management data-
bases (A).
Note: To provide raw data for biobank operators to input
into management databases, persons who collect the
samples are required to generally specify the items summa-
rized in Table 7.
1.19. It is possible to use an ultra-deep freezer (–80°C)
for long-term storage instead of liquid nitrogen storage
containers (B). In this case also, the sample tubes should
preferably be immersed in liquid nitrogen for snap freezing
according to item 1.16, and then placed in the ultra-deep
freezer (A).
Note: The quality of DNA, RNA and proteins extracted
from tissue samples after long-term storage in an ultra-deep
freezer (–80°C) may be poorer than that of those extracted
from tissue samples after long-term storage in liquid nitro-
gen storage containers. (In the case of DNA and RNA in
particular, the quality may deteriorate after 10 or more years
of storage.) (Figs. 8–10 and Table 8).
Note: Although long-term storage in liquid nitrogen stor-
age containers is recommended to facilitate general versa-
tility, DNA and RNA extracted from tissue samples after
long-term storage at 80°C can be used for a number of
analyses without any particular problems. Therefore, the
temperature for long-term storage should be determined at
the discretion of each institution, depending on feasibility
(B). Researchers who use the samples should choose the
analytical method appropriately according to the quality of
the stored samples (A). For this purpose, see the empirical
data in Figs. 8–10 and Table 8.
1.20. Use of any ordinary freezer (–20°C) for long-term
storage should be avoided (N).
1.21. It is desirable for institutions such as biobanks
providing samples to researchers to publish updated results
of studies on the use of biobank samples (e.g., published
papers) on their webpages, etc., in order to provide
researchers with information on the properties and quality of
the stored samples (A).
1.22. It is also desirable for institutions such as biobanks
to regularly conduct demonstrative analysis of a few
randomly selected samples, and to disclose the results (E).
It is desirable for indices of nucleic acid integrity to be
actually measured for all samples, and for the data to be
disclosed when the samples are provided. However, from
the viewpoint of feasibility or unnecessary consumption of
nucleic acid samples, this may not be essential (E).
1.23. Considering the possibility of problems and acci-
dents during long-term storage, it is recommended that a
record of temperature management be provided, if possible
(E).
1.24. Considering the possibility of problems and acci-
dents during long-term storage, it is also desirable to
disperse the samples and store them at separate facilities,
if possible, as a backup archive (E).
Preparation of frozen tissue sections
1.25. When cutting tissue specimens into pieces according
to item 1.10, it is recommended that 1 or 2 pieces
measuring 0.5 0.50.2 cm be taken separately, embed-
ded in embedding medium for preparation of frozen tissue
sections (so-called optimal cutting temperature [OCT] com-
pound), and frozen in dry ice-acetone, etc., for storage in an
ultra-deep freezer (–80°C) (E).
Note: It is recommended that, before they are frozen,
tissue samples should be immersed once in OCT com-
pound and then again in another volume of OCT compound
to prevent the formation of ice crystals during the prepara-
tion of OCT-embedded specimens (E).
1.26. For long-term storage of OCT-embedded speci-
mens in an ultra-deep freezer (–80°C), due caution should
be exercised to prevent the samples from becoming
desiccated, by means such as tightly wrapping the speci-
mens with a material such as Paraﬁlm (Bemis Flexible
Packaging, Chicago, IL, USA), and then placing them in
airtight containers.
Note: Usually, degraded nucleic acids alone can be
extracted from desiccated OCT-embedded blocks (Fig. 11)
(N).
Note: Although the quality of nucleic acids is generally
maintained in OCT-embedded blocks stored for long peri-
ods under optimal conditions, veriﬁcation of the quality of
extracted nucleic acids should be done for each block
before analysis (Fig. 11 and Table 9).
Note: Information on the percentage of cancer cells
contained in the tissue to be provided to researchers can be
obtained by microscopic examination of hematoxylin and
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eosin-stained or immunostained thin sections prepared from
OCT-embedded specimens. To calculate the cancer cell
percentage from microscopic examination of tissue speci-
mens, the following methods are available:
(a) Cancer cells in several ﬁelds of view are counted with a
counter as accurately as possible, and the count is
divided by the total cell count determined similarly
(E), or
Table 7 Sample-associated information that should be deposited in the management databases
Item Description
1. Date of surgery/collection It is indispensable to note multiple episodes of surgery in the same patient.
2. Person who collects the sample When a biobank contact person (pathologist in charge and clinicians in the relevant
specialty, who will collaborate in the study for which the sample is to be used, and who
will judge the propriety of providing of the sample from the biobank to researchers) has
been assigned, the name of the person should be specified.
3. Name of the patient In accordance with the catalogue database, the patient's name should be specified and not
be abbreviated using initial letters or other similar abbreviations.
4. Patient ID
5. Pathology ID This item should be recorded to distinguish multiple episodes of surgery in the same
patient with a single patient's ID.
6. Name of the clinical department Because the name of a department can be a keyword in the catalogue search before
research use, the official names of all clinical departments should be listed. It is also
desirable to build a database into which the person collecting the sample can choose the
official name of the department from a drop-down list in order to prevent typographical
error.
7. Infection information The specific diagnoses that must be confirmed for management and research use of the
sample should be listed in advance, and the person collecting the sample should be
requested to choose the precise diagnosis from the list, with free writing allowed in the
“others“ section.
8. Gender This item is not indispensable at institutions where a catalogue database of the biobank
coupled with electronic medical records is available, where this item is automatically
input from the patient ID.
9. Age at the time of surgery/collection Entry of the patient age at the time of sample collection should be requested, because it is
difficult, at the time when a sample is used for research, to automatically extract the
patient age at the time of sample collection from the electronic medical records.
10. Clinical diagnosis Free writing. This item is used for partial match retrieval in catalogue databases. In
addition, to allow a search from the final diagnosis, it is necessary to couple the biobank
catalogue database with the electronic medical records, in-hospital cancer registry, etc.,
after establishment of the pathological diagnosis, and to thereby enable a search based
on the International Classification of Diseases (ICD) codes, etc.
11. Organ If the name of the organ is used for classification in the management of samples, selection
must be made from a drop-down list of organs, with no free writing option. The World
Health Organization (WHO) tumor classification organ codes may be used.
12. Number of tubes ____ T tubes (tumor/lesion parts), ____ N tubes (non-tumor/control parts).
13. Sample-associated information T1: Site of collection (e.g., lesser curvature of the gastric body, block number #; addition of
photograph/schema of the organ with a mark of the site of sample collection should be
allowed). Free writing of macroscopic findings, etc., should also be permitted.
T2: Similarly, description is requested for the number of sample tubes.
N1: Site of collection (e.g., lesser curvature of the gastric body, block number #; addition of
photograph/schema of the organ with a mark of the site of sample collection should be
allowed). Free description of macroscopic findings, etc., should also be permitted.
N2: Similarly, description is requested for the number of sample tubes.
14. Deviation from the standard operating
procedure (SOP) of the institution
“Present” or “absent” should be chosen. If present, an explanation of the situation should
be given in free writing. However, at an institution where recording of the actual time
between surgical resection and snap freezing of specimens and the temperature (e.g.,
room temperature, 4°C, etc.) at which the surgically resected materials are stored until
freezing is always be requested, a description about the deviation from the SOP may not
be needed.
The following may be speciﬁed if there is a consensus at the institution to allow such speciﬁcation without any difﬁculty.
- Time of resection (24 h system, ___ h ___ min), time of snap freezing (24 h system, ___ h ___ min) or time between surgical resection and snap
freezing (about ___ min)
- Duration of intraoperative ischemia (about ___ min)
- Wet weight (___ mg)
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(b) a rough classiﬁcation, e.g., less than 10%, 10–20%,
and in incremental 10% classes, can be obtained at a
glance by low-power microscopic examination (E).
Useful information can be obtained even using method (b)
(Table 10). Method (a) or (b) should be chosen at each
institution according to feasibility.
Note: Microdissection can be conducted after observation
of histologic features in hematoxylin and eosin-stained thin
sections prepared from OCT-embedded specimens, or
nucleic acids can be extracted without microdissection for
various analyses. Thin sectioning, i.e., destruction of cell
and/or nuclear membranes, may be advantageous for some
Figure 8 Effects of long-term storage temperature on genomic DNA. Using tissue samples stored for a long period of time in an ultra-deep
freezer (–80°C) (a) and in a liquid nitrogen storage container (–180°C) (b), genomic DNA was extracted by ZR-DuetTM DNA/RNA MiniPrep
(Zymo Reseaerch, Irvine, CA) and by the phenol-chloroform method, and the quality of the DNA was assessed by agarose gel
electrophoresis and by genomic PCR with ampliﬁcation lengths of 1241 bp and 2823 bp. (a) In some samples stored for long periods (5–10
years) in an ultra-deep freezer (–80°C), bands representing high-molecular-weight DNA disappeared, indicative of genomic DNA
degradation (blue arrows), and there was no ampliﬁcation by PCR at an ampliﬁcation length of 1241 bp or 2823 bp (red arrows). (b) In
contrast, in samples stored for long periods in liquid nitrogen, such degradation and PCR failure were rare. When using samples stored for
particularly long periods, it is desirable to thoroughly verify the quality of the nucleic acids before performing analysis, because the quality of
DNA may deteriorate with storage at 80°C.
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analyses. On the other hand, contamination by the embed-
ding agent may interfere with the reaction. In particular,
OCT compound may interfere with column puriﬁcation of
nucleic acids and protein analysis.
Note: Preparation of OCT-embedded specimens has the
merit of allowing histologic features to be conﬁrmed, thus
allowing various analyses. However, management of these
samples requires extreme care, including prevention of
desiccation, and this substantially increases the banking
workload, including assessment of the cancer cell percent-
age. Therefore, OCT-embedded specimens should be
prepared taking feasibility into account, and only when there
is adequate consensus.
Research use
1.27. Operations to remove samples from the liquid nitrogen
storage container for research purposes are normally
conducted manually, but as quickly as possible to minimize
any effects of exposure on other samples (A).
Note: High sample quality should be maintained as far as
possible until provision to researchers or the beginning of
transport by placing the tube containing the tissue speci-
mens on dry ice after removal from the container (A).
1.28. Information about the provision of samples and their
intended use should be registered in an appropriate
management application (A).
Note: At biobanks that require the return of extracted
nucleic acids, results of analysis, and remaining pieces of
tissue, the history of usage (researchers, subjects of study,
etc.) should be recorded in precise detail in the manage-
ment databases (E).
Transport
1.29. For samples obtained at institutions that lack facilities
for long-term storage, the tubes containing the tissue
samples should be frozen sufﬁciently in liquid nitrogen or
dry ice-acetone in Dewar bottles and then transported to
institutions that do have liquid nitrogen storage facilities.
Appropriate means of transport should also be used when
supplying samples to researchers in remote locations.
1.30. Usually, non-airtight containers that allow mainte-
nance of temperature (polystyrene containers are a simple
example) ﬁlled with dry ice should be used, and samples
in a frozen state should be entrusted to a forwarding
agency (A).
Figure 9 Effects of long-term storage temperature on RNA quality. Using tissue samples stored for long periods of time in an ultra-deep
freezer (–80°C), total RNA was extracted by ZR-Duet DNA/RNA MiniPrep and TRIzol, and the quality of the RNA obtained was assessed by
measurement of the RIN values in a 2100 Bioanalyzer system and by reverse transcription (RT)-PCR with an ampliﬁcation length of 994 bp.
In some samples stored for long periods (10 years) in an ultra-deep freezer (–80°C), no (RT)-PCR ampliﬁcation was observed at an
ampliﬁcation length of 994 bp (red arrows). In addition, the average RNA integrity number tended to be lower in samples stored for long
periods (10 years) in an ultra-deep freezer (–80°C) (See Table 8). In contrast, such deterioration was rare in samples stored for long periods
in liquid nitrogen (Table 8). When using samples stored for a particularly long period, it is desirable to thoroughly verify the quality of the
nucleic acids before performing analysis, because the quality of RNA may deteriorate with storage at 80°C.
Figure 10 Effects of storage in an ultra-deep freezer (–80°C) on
the quality of protein. Liver tissue stored for up to 2 years in an
ultra-deep freezer (–80°C) was dispersed and crushed in protease
inhibitor-containing radio-immunoprecipitation assay (RIPA) buffer.
The samples were subjected to gelation, washing, dehydration,
reduction treatment, and trypsin digestion by the usual methods,29
and proteome analysis was conducted by liquid chromatography-
electrospray ionization-quadrupole-time of ﬂight mass spectrometry
(LC/ESI-QTOF MS). It became apparent that storage for 2 years or
more in an ultra-deep freezer (–80°C) was associated with a
decrease in the number of proteins and peptides detected. In
contrast, in the samples stored for long periods of time in liquid
nitrogen, such proteome analysis failure was rare. When using
samples stored for a particularly long period, it is desirable to
thoroughly verify the quality of the proteins before performing
analysis, because protein quality may deteriorate following storage
at 80°C.
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Note: Some forwarding agencies specializing in the
delivery of biological samples guarantee temperature main-
tenance (e.g., at 80°C) and use transport containers with
a built-in temperature recording chip (E). However, for
samples that are transported in a frozen state using
polystyrene containers ﬁlled with dry ice, there is no clear
indication of any deterioration in the quality of extracted
nucleic acids within a few days, even if such specialist
forwarding agencies are not employed (Figs. 12, 13 and
Tables 11, 12).
Biosafety
1.32. If tissue banking operations are likely to pose a risk of
exposure to infectious agents, even in cases where only a
Table 8 Effects of long-term storage temperature on the quality of RNA
RNA integrity number
Storage
temperature Organ
Storage
period
Number of analyzed tissue
specimens MeanSD
P-value against 1-year storage (Welch-t
test)
–80°C Breast 1 year 5 8.00.5
5 years 5 7.90.4 7.93101
10 years 5 5.02.9 8.75102
Ovary 1 year 5 7.30.6
5 years 5 6.82.2 6.20101
10 years 3 5.43.4 4.19101
Colon 1 year 5 7.91.0
5 years 5 6.22.0 1.27101
10 years 5 4.42.3 2.53102
–180°C Kidney 1 year 11 7.41.9
5 years 2 7.1 8.60101
10 years 12 6.80.8 4.44101
Cases with P< 0.05 are underlined. Also see Fig. 9.
Figure 11 The quality of RNA extracted from specimens embedded in optimal cutting temperature (OCT) compound. OCT-embedded
specimens were prepared from surgical specimens of consecutive cases of biliary tract cancer, stored for a long period in an ultra-deep
freezer (–80°C), and cut into thin sections to extract total RNA. RNA integrity numbers (RINs) were then determined using a 2100
Bioanalyzer system. Notwithstanding the same period of storage, there were some samples that showed extremely low RIN values (red),
presumably resulting from the effects of desiccation in the ultra-deep freezer. It was considered important to protect OCT-embedded
specimens from desiccation by some means, such as tightly packing them in Paraﬁlm, etc., and putting the packed specimens in airtight
containers. After excluding the dried specimens, 215 samples with RIN values of 6.0 or more were subjected to subsequent analyses (Table
9). In the 215 samples analyzed, the relationship between the storage period and the quality of the RNA was described in Table 9. When
samples with extremely low RIN values resulting from desiccation were excluded, it was possible to extract RNA of good quality, indicating
that long-term storage of OCT-embedded specimens in an ultra-deep freezer (–80°C) does not cause any marked deterioration in the quality
of the RNA.
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portion of the specimen contains infectious agents, all
samples should be handled as biohazards.
1.33. Biobank managers should refer to appropriate docu-
ments, such as “National Cancer Institute (NCI) Best Practices
for Biospecimen Resources” (ﬁrst released in 2007 and
updated in both 2011 and 2016),23 “World Health Organization
(WHO): Biorisk Management; Laboratory Biosecurity Guid-
ance (2006)”24 and “Organisation for Economic Co-operation
and Development (OECD): Best Practice Guidelines on
Biosecurity for Biological Resource Centres (2007)”,25 to
formulate safety handling manuals, and to ensure all operators
clearly understand the contents of the manuals.
1.34. Operators must read safety handling manuals with
care, and perform their activities according to the methods
speciﬁed therein. In addition, managers must provide the
operators with appropriate training.
Table 9 The quality of RNA extracted from specimens embedded in optimal cutting temperature (OCT) compound
RNA integrity number
Storage period
Number of analyzed
tissue samples† A260/A280 MeanSD
P-value against storage for less
than 1 year (Welch-t test)
Less than 1 year 18 2.050.06 8.10.5 –
1 year to less than 2 years 11 2.030.16 8.01.2 7.89101
2 years to less than 3 years 20 2.110.13 8.50.8 8.48102
3 years to less than 4 years 21 2.040.11 8.40.9 2.91101
4 years to less than 5 years 13 2.050.22 8.60.9 7.52102
5 years to less than 6 years 27 2.050.08 8.01.1 5.34101
6 years to less than 7 years 26 2.040.08 8.50.9 9.57102
7 years to less than 8 years 22 2.080.07 8.51.0 1.48101
8 years to less than 9 years 21 2.060.07 7.90.9 3.96101
9 years to less than 10 years 30 2.070.07 8.01.0 5.07101
†Detailed description of analyzed tissue specimens is shown in the legend for Fig. 11. Also see Fig. 11.
Table 10 Representative cases revealing the signiﬁcance of at-a-glance assessment of the proportion (percentage) of cancer cells for
interpretation of mutant allele frequency
Amplicon sequencing
Read
depth
Mutant allele
frequency (%)
Proportion of tumor cells as assessed
by the pathologist at a glance (%) Interpretation of the results
45 989 48.76 90 Proportion of cancer cells0.5¼mutant allele frequency!Mutation in
unilateral allele?
3560 50.22 80 Proportion of cancer cells0.5¼mutant allele frequency!Mutation in
unilateral allele?
2321 59.11 80 Proportion of cancer cells0.5¼mutant allele frequency!Mutation in
unilateral allele?
17684 53.15 90 Proportion of cancer cells0.5¼mutant allele frequency!Mutation in
unilateral allele?
6309 3.53 10 Proportion of cancer cells0.5¼mutant allele frequency!Mutation in
unilateral allele?
5113 54.57 30 Generally 50%, unlike the mutant allele frequency predicted from the
percentage of cancer cells!Heterozygous or germline mutation
133 11.28 80 Mutant allele frequency inconsistent with the proportion of cancer
cells!Read depth is also shallow, indicating artifact or heterogeneity
5279 83.16 80 Proportion of cancer cells¼mutant allele frequency!Mutation in both
alleles?
8335 51.22 20 Generally 50%, unlike the mutant allele frequency predicted from the
proportion of cancer cells!Heterozygous or germline mutation
14506 9.27 80 Mutant allele frequency inconsistent with the proportion of cancer
cells!Heterogeneity?
In 10 hematoxylin and eosin-stained samples of non-small cell lung cancer, a pathologist assessed the proportion (percentage) of cancer cells at a
glance under low magniﬁcation and classiﬁed them in 10% groups, such as <10%, 10%  <20%, etc. Cases in which the proportion of cancer cells
assessed at a glance was useful for interpretation of the read depth and mutant allele frequency obtained using the TruSeq Cancer Panel (Illumina,
San Diego, CA, USA) using genomic DNA extracted from the same specimen are shown in this table. Useful ﬁndings may be obtained by at-a-glance
assessment of the proportion of cancer cells under low magniﬁcation, even without actual determination of the cancer cell count and the total cell
count using a counter.
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Note: Speciﬁcally, preventive measures similar to those in
clinical practice must be adopted in addition to the general
safety control measures used in the laboratory. Namely,
operators should wear gloves and face shields and be
vigilant about hand washing.
Note: In particular, due caution should be exercised to
prevent tuberculosis infection, which pathologists and clini-
cal laboratory technicians involved in pathology are at a
high risk of contracting.26
1.35. If there is a possibility of exposure to droplets and
aerosols, the containers of the samples should be opened
in a safety cabinet in accordance with Biosafety Level 2
prescribed in the “WHO: Laboratory Biosafety Manual, 3rd
edn. (2004)”.27
1.36. All operators in biobanks should be vaccinated
against hepatitis virus B, etc., and all exposed operators
must receive post-exposure examinations, and be followed
up as appropriate.
Disposal of samples
1.37. When disposal of frozen pathological tissue is
necessary because of withdrawal of consent by the
Figure 12 Effects of the method of transport of samples on the quality of genomic DNA. Tissue pieces of almost the same size (2 to
3mm3) collected from the same site (non-cancerous part) of the surgical specimen from the same patient were transported by various
methods after they were immediately subjected to snap freezing and storage for a certain period in liquid nitrogen, and genomic DNA was
extracted by the phenol-chloroform method to compare the quality of DNA. The processing procedures for comparison were as follows: #1,
Snap freezing in liquid nitrogen immediately after surgical resection, and no transport; #14, Snap freezing in liquid nitrogen immediately after
surgical resection, and 2-day transport by a forwarding agency specialized in the delivery of biologic samples that guarantees temperature
maintenance at 80°C, and uses transport containers with a built-in temperature recording chip; #15, Snap freezing in liquid nitrogen
immediately after surgical resection, and 2-day transport by a forwarding agency that uses polystyrene containers ﬁlled with dry ice.
Extraction and assessment of the quality of genomic DNA were performed by the same operator in the same laboratory. The quality of DNA
was assessed by agarose gel electrophoresis, by DNA integrity number (DIN) measurement in a 2200 TapeStation system (Table 11), and
by genomic PCR with ampliﬁcation lengths of 1241 bp and 2823 bp. As shown in this ﬁgure and Table 11, if the methods of collection and of
storage prior to the transport are appropriate, the method used for transport of the samples appears to exert no marked effects on the
quality of the genomic DNA.
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Figure 13 Effects of sample transport method on RNA quality. Tissue pieces of almost the same size (2 to 3mm3) collected from the same
site (non-cancerous part) of the surgical specimen from the same patient were transported by various methods after they had been
immediately subjected to snap freezing and storage for a certain period in liquid nitrogen, and total RNA was extracted using TRIzol to
compare the quality of the RNA. The processing procedures for comparison were as follows: #1, Snap freezing in liquid nitrogen immediately
after surgical resection, and no transport; #14, Snap freezing in liquid nitrogen immediately after surgical resection, and 2-day transport by a
forwarding agency specializing in the delivery of biologic samples that guarantees temperature maintenance at 80°C and uses transport
containers with a built-in temperature-recording chip; #15, Snap freezing in liquid nitrogen immediately after surgical resection, and 2-day
transport by a forwarding agency that uses polystyrene containers ﬁlled with dry ice. Extraction and assessment of the quality of all the RNA
were performed by the same operator in the same laboratory. The quality of RNA was assessed by measurement of the RNA integrity
number (RIN) in a 2100 Bioanalyzer system (Table 12) and by reverse transcription (RT)-PCR with an ampliﬁcation length of 994 bp. As
shown in this ﬁgure and Table 12, if the methods of sample collection and storage prior to transport are appropriate, the method used for
transport of the samples appears to have no marked effects on the quality of the RNA.
Table 11 Effects of transport method on the quality of genomic DNA
DNA integrity number
Procedure
Number of
analyzed tissue
specimens†
Yielded
genomic
DNA (mg) A260/A280 MeanSD
P-value
against #1
(Welch-t test)
#1 Snap freezing in liquid nitrogen immediately after surgical resection,
and no transport
12 190.0 104.0 1.87 0.03 9.5 0.5 –
#14 Snap freezing in liquid nitrogen immediately after surgical resection,
and 2-day transport by a specialized forwarding agency at 80°C
3 260.7 119.2 1.89 0.03 9.5 0.4 1.00
#15 Snap freezing in liquid nitrogen immediately after surgical resection,
and 2-day transport by a forwarding agency using polystyrene
containers filled with dry ice
3 269.7 157.5 1.92 0.02 8.9 0.3 7.05 102
†Detailed description of analyzed tissue specimens is shown in the legend for Fig. 12. Also see Fig. 12.
Table 12 Effects of the method of transport of the samples on the quality of RNA
RNA integrity numebr
Procedure
Number of
analyzed tissue
specimens†
Yielded
total RNA
(mg) A260/A280 MeanSD
P-value
against #1
(Welch-t test)
#1 Snap freezing in liquid nitrogen immediately after surgical resection,
and no transport
12 190.0 104.0 1.87 0.03 9.50.5 –
#14 Snap freezing in liquid nitrogen immediately after surgical resection,
and 2-day transport by a specialized forwarding agency at 80°C
3 123.9 18.1 2.10 0.01 6.70.4 9.55 101
#15 Snap freezing in liquid nitrogen immediately after extraction, and 2-
day transport by a forwarding agency using polystyrene containers
filled with dry ice
3 36.6 38.8 2.07 0.03 6.91.2 7.59 101
†Detailed description of analyzed tissue specimens is shown in the legend for Fig. 13. Also see Fig. 13.
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sample donor for use in research, or for other reasons,
the sample should be treated as pathological waste
(resected organs and tissues, etc.), and the date and
reason for disposal should be recorded in the manage-
ment database.
PART 2: APPROPRIATE METHODS FOR
PREPARATION AND STORAGE OF FFPE SPECIMENS
In order to minimize any degeneration of DNA, RNA and
proteins, etc., maintain high sample quality during long-term
Figure 14 Effects of the time until ﬁxation, the ﬁxation time, and the type and concentration of formalin on the quality of DNA. At 15
institutions participating in a multicenter study, a verbal survey was conducted concerning the average time until ﬁxation of surgical
specimens, the ﬁxation time, and the type and concentration of formalin used in the routine procedure for preparation of pathological tissue
samples. Using formalin-ﬁxed parafﬁn-embedded specimens prepared at the 15 institutions, the DCT values against control DNA were
determined by real-time PCR to verify the quality of DNA by TruSight Tumor (Illumina). Preparation of a library for a search of cancer-related
gene mutations by next-generation sequencing is expected to be possible for cases with DCT <4 (blue line).30 As shown in red, ﬁxation in
10% buffered formalin soon after surgical resection (within about 3 h) and cutting of the specimen on the day after surgery were considered
desirable.
Figure 15 Effects of ﬁxation time and the type and concentration of formalin on the quality of DNA. Colonic mucosa (C) and liver (L)
specimens obtained at autopsy within 3 h of death were analyzed at a single institution. Genomic DNA was extracted using the QIAamp
DNA FFPE Tissue kit (Qiagen, GmbH, Hilden, Germany) and the DNA integrity numbers (DINs) were determined using TapeStation-
genomic DNA. Here, preparation of a library allowing amplicon sequencing was considered possible at a probability of 70% or more for
samples with DIN values of 2.3 or higher (blue line) (H. Nishihara, unpubl. data, 2015). Fixation in highly buffered (0.05M) 10% formalin
within 1–3 days is desirable (red arrows). It is possible to increase the concentration of highly buffered formalin for ﬁxation within 1–3 days,
as long as attention is paid to conservation of the morphology (blue arrows). At institutions where the ﬁxation time cannot be reduced to 3
days or less, it is indispensable to use highly buffered formalin. It is considered that analysis is possible using specimens ﬁxed for less than
a day if unbuffered formalin is used.
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storage, and maximize the versatility of samples for use in a
variety of analyses in the future, appropriate methods for
preparation of FFPE specimens that are applicable to
genomic studies as well as to routine pathological diagnosis
are speciﬁed in this section. Explanatory notes, (E), (A), (B)
and (N), are the same as those in Part 1.
FFPE specimens are prepared from surgical or biopsy
specimens mainly for routine pathological diagnosis. Even
at institutions where parafﬁn-embedded specimens are
mostly prepared for research use, the processes of
ﬁxation and cutting of surgical specimens are inseparable
from those used in routine handling of specimens.
Therefore, it is important that the present recommended
rules are incorporated as far as possible at each institu-
tion, while respecting each institution's conventional
method(s) for preparing FFPE specimens for pathological
diagnosis.
Timing of ﬁxation
2.1. Tissue specimens should be immersed in ﬁxative as
soon as possible after resection (A).
2.2. At institutions where immediate ﬁxation is not feasi-
ble, it is desirable for surgically resected material to be kept
refrigerated (4°C) until it is subjected to ﬁxation within about
3 h (Fig. 14) (B).
Note: Leaving surgically resected material at room tem-
perature for more than 30min should be avoided as far as
possible (N).
2.3. Insufﬁcient ﬁxation must be avoided (N).
Figure 16 Effects of ﬁxation time and the type and concentration of formalin on the quality of RNA. At a single institution, colonic mucosa
(C) and liver (L) specimens obtained at autopsy within 3 h of death were analyzed. Total RNA was extracted using the RNeasy FFPE Kit
(Qiagen) and the RNA integrity numbers (RINs) were determined using TapeStation. Unlike the effects on the quality of DNA described in
Fig. 15, use of 15% or 20% formalin tended to provide RNA of higher quality than the use of 10% formalin. The quality of RNA also tended
to be better with ﬁxation for 3–7 days than with ﬁxation for 1 day. Namely, in cases of RNA analysis, more thorough ﬁxation relative to the
optimal conditions for DNA analysis may yield better results, for a variety of possible reasons, including complete inactivation of RNase. It is
considered that the conditions of ﬁxation should be chosen according to the purpose for which the samples are used.
Figure 17 Effects of formalin-free ﬁxative on the quality of genomic
DNA. Using surgical specimens obtained from the same patients
with ovarian, gastric or lung cancers, formalin-ﬁxed parafﬁn-embed-
ded (FFPE) specimens ﬁxed for 3–5 days in 10% neutral buffered
formalin and PAXgene31-ﬁxed parafﬁn-embedded (PFPE) speci-
mens ﬁxed for 4-6 h in PAXgene Tissue container (Qiagen) were
prepared. Genomic DNA was extracted from 2 to 4 sections 8mm
thick by QIAsymphony (Qiagen). The quality of genomic DNA was
generally equivalent in both types of specimens, although it tended
to be better in some PFPE specimens; there were no statistically
signiﬁcant differences between the two types of specimens in this
experiment. Subsequently, mutations of cancer-related genes were
searched for in the same genomic DNA samples using the
Comprehensive Cancer Panel (Qiagen), which revealed no distinct
differences in the detected mutations among samples 2, 3 and 4, for
which no evident differences in the DNA integrity numbers (DINs)
were observed between the FFPE and PFPE specimens (also see
Table 13). In contrast, for samples 1, 5, 6 and 7, for which the FFPE
specimens showed lower DIN values, the threshold for the number
of reads representative of signiﬁcant mutations had to be set up
appropriately because of the high frequency of C/T substitution
including artifacts based on the formalin ﬁxation-related deamination
reaction of cytosine.23 Whereas highly reliable analysis can be
carried out using genomic DNA extracted from PFPE specimens,
genomic analyses such as mutation analysis are also possible with
FFPE specimens, when appropriate conditions are set.
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Note: Insufﬁcient ﬁxation causes a marked decrease in
the quality of DNA, RNA, and protein.
Note: It is necessary to secure a sufﬁcient ﬁxation time,
considering that the inﬁltration rate of formalin, the most
common ﬁxative, is about 1mm/h. Before proceeding to
ﬁxation, the tissue specimen should be sliced at an
appropriate thickness that allows sufﬁcient ﬁxation prior to
cutting out (A).
Concentration and type of ﬁxative
2.4. It is desirable to use neutral buffered formalin solution,
not an unbuffered (acidic) solution, for ﬁxation (Figs. 14, 15)
(A).
2.5. When intending to use the extracted DNA for analysis,
it is desirable to use 10% formalin (3.5% formaldehyde) rather
than 20% formalin (7% formaldehyde) for ﬁxation (Fig. 15) (A).
Figure 18 Effects of formalin-free ﬁxative on immunohistochemistry. Formalin-ﬁxed parafﬁn-embedded (FFPE) specimens and
PAXgene31-ﬁxed parafﬁn-embedded (PFPE) specimens were prepared from surgical specimens obtained from the same patients
with brain tumor and thyroid, breast or colon cancers (specimens of equal size were obtained from the opposite side to each other
in the cases of brain tumor, thyroid and breast cancers, whereas specimens were obtained from a different site in the case of
colon cancer), and the results of immunohistochemistry using various antibodies were assessed. In this experiment, although non-
speciﬁc stainability was slightly higher in the PFPE specimens when 40min antigen retrieval was used, reduction of the antigen
retrieval time to 5min yielded favorable results. Thus, PAXgene ﬁxation is considered to be suitable for immunohistochemical
studies.
Table 13 Effects of formalin-free ﬁxative on the quality of genomic DNA
DNA integrity number
Tissue specimens†
Number of analyzed
samples
Yielded genomic
DNA (mg) A260/A280 MeanSD
P-value against #1
(Welch-t test)
Formalin-fixed paraffin-embedded
specimens
7 4.011.98 1.930.03 6.871.31 –
PaxGene-fixed paraffin-embedded
specimens
7 7.903.90 1.970.24 8.360.85 6.70102
†Detailed description of analyzed tissue specimens is shown in the legend for Fig. 17. Also see Fig. 17.
© 2018 The Authors. Pathology International published by Japanese Society of Pathology and John Wiley & Sons Australia, Ltd
84 Y. Kanai et al.
Note: However, for analysis using RNA, more thor-
ough ﬁxation using 20% formalin (7% formaldehyde)
relative to the optimal conditions of analysis for
DNA may yield better results, because RNase
becomes completely inactivated (Fig. 16). Therefore,
ﬁxation conditions should be chosen according to the
purpose for which the study samples are to be used/
applied.
Figure 19 Effects of formalin-free ﬁxative on the
quality of RNA. Using surgical specimens obtained
from the same patients with ovarian, gastric or lung
cancers, formalin-ﬁxed parafﬁn-embedded (FFPE)
specimens ﬁxed for 3–5 days in 10% neutral buffered
formalin and PAXgene31-ﬁxed parafﬁn-embedded
(PFPE) specimens ﬁxed for 4–6h in PAXgene Tissue
container were prepared. Total RNA was extracted
from 2 to 4 sections 8mm thick by QIAsymphony
(Qiagen). In this experiment, the RNA integrity number
(RIN) was generally equivalent in both types of speci-
mens, tending to sometimes be worse in the PFPE
specimens. It was presumed that ﬁxation in PAXgene
for 4–6h resulted in insufﬁcient ﬁxation. It appeared
that the results of RNA analysis are more susceptible
to the inﬂuence of insufﬁcient ﬁxation than those of
DNA analysis. For analysis of RNA, in particular,
PAXgene ﬁxation should be conducted for 12–24h.
Figure 20 Effects of overﬁxation on the quality of genomic DNA. Using formalin-ﬁxed parafﬁn-embedded surgical specimens from a total of
53 patients with colon and uterine corpus cancers, genomic DNA was extracted and its quality was assessed by the comparative Ct
method.33 Using 10ng of genomic DNA that satisﬁed the quality criteria, cancer-related gene mutations were searched for by means of
amplicon sequencing with Ion AmpliSeqTM Cancer Hotspot Panel v2 (Thermo Fisher), using the semiconductor sequencer Ion PGM (Thermo
Fisher). The TaqMan RNaseP Detection Reagent Kit (Thermo Fisher) and TaqMan MGB gene expression Kit (Thermo Fisher) were used.
The relative value ratio (quality control [QC] value) of the Ct value for short amplicon (86 bp)/long amplicon (256 bp) was 0.82 on average,
and the QC value of 0.2 recommended by Thermo Fisher was met in 94% of the specimens (50 cases). Genomic DNA that satisﬁed the QC
value criterion allowed synthesis of a sufﬁciently sized library for base sequence analysis. In the 50 cases for which the QC values met the
criteria, a mean map read number of 638 661, map rate of 93%, and mean read depth of 2759 were obtained, and base sequence analysis
by amplicon sequencing was conducted successfully in all cases. The frequency of C/T substitution including artifacts based on the formalin
ﬁxation-related deamination reaction of cytosine32 was higher in the samples collected before 2011, but markedly decreased in the samples
collected in or after 2011 (red line). At this institution, the ﬁxation time for each surgically resected specimen has been reduced since around
2011, by adjusting the cutting day. Blocks were cut twice every week after the end of March 2012, and every day after April, 2013, reducing
the time until cutting to 2–3 days. The frequency of C/T substitution is considered to be signiﬁcantly affected by ﬁxation time as well as time-
related deterioration. To ensure accurate analysis, overﬁxation exceeding 1 week should be avoided, as a rule.
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Note: Several tissue ﬁxatives not containing formalin
have been developed and are currently available commer-
cially. Some of them have been demonstrated to be of
sufﬁcient quality for histological observation, and superior
for preservation of nucleic acids, proteins, etc. (Figs. 17, 18
and Table 13).
Note: When conducting analysis of RNA using tissue
ﬁxatives not containing formalin, more thorough ﬁxation
relative to the optimal conditions for DNA analysis may yield
favorable results (Fig. 19).
Note: At institutions possessing apparatuses that can be
used for preparation of specimens in the absence of
formalin, and where there is consensus among the staff
involved, parafﬁn-embedded specimens that have under-
gone non-formalin ﬁxation are recommended for research
purposes, in parallel with routine FFPE specimens (E).
Figure 21 Effects of overﬁxation on immunohistochemistry. Parafﬁn-embedded specimens were prepared from colonic mucosa of the
same patient using various periods of formalin ﬁxation, and subjected to immunohistochemistry with anti-Ki-67 antibody (MIB-1, Agilent).
The results indicated that overﬁxation would interfere with accurate assessment of the MIB-1-labeling index; therefore, overﬁxation should
be avoided.
Figure 22 Effects of the state of preservation of unstained slides on genomic DNA. (a) Effects of the state of preservation of unstained
slides on the quality of genomic DNA. Using unstained 5mm-thick sections prepared from surgical specimens of the large intestine and lung
ﬁxed in formalin for 3 days and embedded in parafﬁn, the following storage conditions were compared: (i) Storage at room temperature
without parafﬁn coating, (ii) Storage at room temperature with parafﬁn coating, (iii) Storage at 4°C without parafﬁn coating, and (iv) Storage
at 4°C with parafﬁn coating. These samples were stored for 1 or 3 months, deparafﬁnized with xylene, and subjected to extraction of
genomic DNA with the QIAamp DNA FFPE Tissue kit. The yield of double-stranded DNA was assessed by the Qubit system (Thermo
Fisher), and the quality of DNA was assessed by the DNA integrity numbers (DINs) determined using the TapeStation system. Although the
DIN values were slightly lower in the samples stored for 3 months than in those stored for 1 month, it is considered that unstained slides
stored for 3 months can be used favorably for analysis of the DNA. Whether the samples were stored at room temperature or 4°C, and
whether unstained slides were parafﬁn-coated or not appeared to exert no marked inﬂuence on the quality of the DNA. RT; room
temperature, Coat; parafﬁn coating. (b) Effects of parafﬁn coating of unstained specimens on the yield of genomic DNA. A comparison of
the yields of genomic DNA from specimens after storage for 3 months showed that the yield from parafﬁn-coated unstained slides tended to
decrease, perhaps depending on the thoroughness of the deparafﬁnization process. RT, room temperature; Coat, parafﬁn coating.
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Fixation time
2.6. It is desirable to avoid overﬁxation and to cut blocks on
an adequate number of occasions (A). Although it is most
desirable to conduct cutting the day after surgery (within
24h) (E), reasonably favorable preservation of nucleic acids
and other elements can be expected when cutting is
conducted within 3 days of surgery (Figs. 14, 15, 20, 21) (A).
Figure 23 Effects of the state of preservation of unstained slides on immunohistochemistry. Unstained 5mm-thick sections prepared from
surgical specimens of the (a) colon and (b) lung ﬁxed in formalin for 3 days and embedded in parafﬁn were stored for 2 months under the
following storage conditions, and then subjected to immunohistochemical studies using anti-Ki-67 antibody (MIB-1, Agilent). The following
storage conditions were compared: (i) Storage at 4°C without parafﬁn coating, (ii) Storage at 4°C with parafﬁn coating, (iii) Storage at room
temperature without parafﬁn coating, (iv) Storage at room temperature with parafﬁn coating, (v) Storage in a high-temperature and humid
environment without parafﬁn coating, and (vi) Storage in a high-temperature and humid environment with parafﬁn coating. Although the
stainability was slight in comparison with that just after sectioning, no interference with the results of the MIB-1 labeling index was observed
for any sample, and there was also no marked difference of stainability in relation to parafﬁn coating.
© 2018 The Authors. Pathology International published by Japanese Society of Pathology and John Wiley & Sons Australia, Ltd
JSP Guidelines for Genomic Research 87
Note: It is desirable to avoid ﬁxation in formalin for more
than 1 week (Figs., 21 20) (N).
Handling of unstained slides
2.7. In general, it is recommended to conduct extraction of
nucleic acids from unstained slides as soon as possible
after thin sectioning, and it is generally considered that
unstained slides should be kept at 4°C if they need to be
stored for a certain period of time for research reasons.
However, there are generally no effects on the quality of
nucleic acids even when the specimens are kept at room
temperature, provided that the storage period is not too
long (Fig. 22a).
2.8. Many institutions use parafﬁn coating for unstained
slides. Parafﬁn coating of unstained slides, which reduces
dust and physical damage, generally has no obvious
inﬂuence on the quality of nucleic acids (Fig. 22a).
Note: When unstained slides are coated with parafﬁn, it is
necessary to perform thorough deparafﬁnization before
analysis (Fig. 22b).
Note: Lack of parafﬁn coating of unstained slides does
not cause any particular problems in immunohistochemical
studies (Fig. 23).
2.9. When unstained slides are to be stored for a certain
period of time for research reasons, extremely bad
conditions such as exposure to direct sunlight should be
avoided (N).
Decalciﬁcation
2.10. If there is a possibility that samples containing hard
tissues may be subjected to genomic studies, decalciﬁca-
tion with ethylenediaminetetraacetic acid should be per-
formed (A), while rapid decalciﬁcation (Plank-Rychlo
method)28 should be avoided (Fig. 24) (N).
PERSPECTIVES
Even though the Guidelines issued so far have focused on
procedures for use of pathological tissue samples for
research purposes, the fruits of genome research have
been rapidly introduced into clinical practice over the last
few years. Genome research should provide continuous
support to clinical practice to facilitate precise and personal-
ized medicine based on clinical sequencing of genomic
material from pathological tissue samples. In this context,
the bioresource banking system is becoming more perva-
sive among various institutions. In view of the constant
innovations being made in wet analytical techniques and
improvements in the dry bioinformatics pipelines, such as
the application of artiﬁcial intelligence to deal with integrated
Figure 24 Effects of decalciﬁcation method on the quality of genomic DNA. Surgical specimens from a patient who underwent
mandibulectomy for gingival squamous cell carcinoma were ﬁxed in formalin and processed into parafﬁn-embedded (FFPE) blocks.
Genomic DNA was extracted from thin sections with a total thickness of at least 20mm using the QIAamp DNA FFPE Tissue Kit to compare
the quality of the DNA. Samples decalciﬁed rapidly by the Plank-Rycholo method and parafﬁn embedded for routine histopathological
diagnosis (Plank) and samples decalciﬁed with 10% ethylenediaminetetraacetic acid and parafﬁn embedded for research use (EDTA) were
compared. Less fragmented DNA was occasionally extracted from the FFPE blocks processed by formalin ﬁxation for a few days and
decalciﬁcation in EDTA (red frames and red arrow). Fragmentation of genomic DNA (about 50-300bp) was often observed when the
duration of formalin ﬁxation before decalciﬁcation with EDTA was prolonged. Extraction of genomic DNA of suitable quality for genomic
analysis is difﬁcult after decalciﬁcation by the Plank-Rychlo method carried out for routine histopathological diagnosis.
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multi omics data, appropriate handling of pathological tissue
samples is now a key issue essential to the success of
genome research. The JSP intends to update its guidelines
regularly to ensure that they incorporate the most up-to-
date analytical techniques.
On the other hand, as next-generation sequencing using
targeted gene panels is now being performed widely in a
clinical setting, appropriate procedures for the handling of
pathological tissue samples for both research and clinical
purposes are basically becoming standardized. However,
speciﬁc procedures for clinical purposes focusing more on
next-generation sequencing will need to be developed using
the research-oriented guidelines as a basis.
In the near future, the fruits of both genome research and
genome medicine based on pathological tissue samples will
be reapplied to histopathological research and diagnostic
pathology in practice: The histological classiﬁcation of malig-
nant tumors derived from various organs will be reorganized
so that it better reﬂects the somatic mutation spectrum and
multiomics data proﬁles. In this way, genome research and
histopathological research will become an inseparable com-
bination for realization of precise and personalized medicine.
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